Arguments in favour of remdesivir for treating SARS-CoV-2 infections

Detalles Bibliográficos
Autores principales: Ko, Wen-Chien, Rolain, Jean-Marc, Lee, Nan-Yao, Chen, Po-Lin, Huang, Ching-Tai, Lee, Ping-Ing, Hsueh, Po-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135364/
https://www.ncbi.nlm.nih.gov/pubmed/32147516
http://dx.doi.org/10.1016/j.ijantimicag.2020.105933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135364/
https://www.ncbi.nlm.nih.gov/pubmed/32147516
http://dx.doi.org/10.1016/j.ijantimicag.2020.105933

Ejemplares similares